International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson … – GlobeNewswire (press release)
Health Essentials from Cleveland Clinic (blog) |
International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson …
GlobeNewswire (press release) CARLSBAD, Calif., May 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that … Will Stem Cell Research Change Treatment of Heart Disease? Stem Cell Therapy Global Market Size, Growth, Share, Trends and Forecast by 2022- Market Research report 2016 |
